Gordagen Appoints Gregory Macosko to Board of Directors

MELBOURNE, Australia, July 29 (Bernama) --

Mr. Macosko will be the Company's first US-based Board member

29 July 2015, Melbourne, Australia - Gordagen Pharmaceuticals, a private biopharmaceutical and nutraceutical company developing tocotrienols, today announced the appointment of Gregory Macosko to its board of directors, effective August 1, 2015. With this addition, its Board now consists of 5 directors of which 3 directors are non-executive and independent.

http://www.bernama.com/bernama/v8/newsindex.php?id=1156444